ClinicalTrials.gg
CompletedNCT04774029Updated Feb 26, 2021

Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management

An Early Phase 1 interventional study of Basivertebral nerve block and Lidocaine induced basivertebral nerve block in Vertebral Compression, Vertebra Compression Fracture and Vertebral Fracture, sponsored by Northwell Health. Completed at 1 site in United States. Open to participants aged 50 Years to 100 Years. Per ClinicalTrials.gov, last updated 2021-02-26.

Sponsored by Northwell Health · Early Phase 1, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was Apr 2020, 6 years 7 months ago, and no results have been posted to the registry.
  • Registered 1 year 1 month after the study started (first participant enrolled Jan 2020, registered Feb 2021).
Phase
Early Phase 1
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
50 Years to 100 Years
Sex
All
01

Study summary

The goal of this study is to assess the efficacy of lidocaine basivertebral nerve block as intraprocedural anesthesia during vertebral augmentation procedures.

Read the detailed description

Vertebral compression fractures secondary to osteoporosis can be treated with vertebral augmentation. Since intraprocedural pain is common during vertebral body endplate manipulation, these procedures are often carried out using conscious sedation or general anesthesia. Research has shown that the vertebral endplates are innervated by the basivertebral nerve, which has been successfully targeted via radiofrequency ablation to treat chronic vertebrogenic lower back pain. With this physiology in mind, the investigators will attempt to treated participants with vertebral compression using lidocaine-induced intraosseous basivertebral nerve block as the primary intraprocedural analgesia.

02

Conditions studied

  • Vertebral Compression
  • Vertebra Compression Fracture
  • Vertebral Fracture

Keywords

  • Basivertebral nerve block
  • Vertebral augmentation
  • BVN block
  • Kyphoplasty
  • nerve block
  • compression fracture
03

In context

Spinal Fractures

144 studies on the registry are indexed under Spinal Fractures; 24 are open to participants now.

This study's enrollment of 10 is below the median of 85 across 85 interventional studies indexed under Spinal Fractures.

Browse Spinal Fractures studies →

Lead sponsor

Northwell Health is the lead sponsor of 475 studies on the registry; 107 are open to participants now.

Of its 45 completed or terminated interventional studies of FDA-regulated products, 23 (51%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >50 years old
  • Patient must have a diagnosis of osteoporosis on dual energy x-ray absorptiometry (DEXA),
  • Patient must have an acute or subacute single level vertebral compression fracture between T10 - L3 as confirmed via magnetic resonance imaging (MRI) or nuclear medicine bone scan,
  • Patient must have an initial pain score of greater than or equal to five using a standard 0-10 Visual Analog Scale subjective pain score upon initial consultation.

Exclusion criteria

Exclusion Criteria:

  • Pathologic compression fracture, such as due to disease
  • Age >90 years old or \<50 years old
  • Pregnancy
  • Diagnosed Anxiety Disorder
  • Diagnosed Depression Disorder
  • Diagnosed Psychotic Disorder
  • Diagnosed Mental Disease Disorder
  • Diagnosed Parkinson's disease/other movement disorders/or cerebellar dysfunction
  • (ECOG) score at baseline prior to compression fracture >1
  • Back Pain scores at time of initial consult \<5, using a standard Visual Analog Scale
  • Illicit drug dependence or abuse
  • Alcohol dependence or abuse
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

ECOG performance status

A scale of how much an illness limits everyday activity. For people being assessed to join a study, scores run from 0 (fully active) to 4; lower is more active.

0
Fully active, no restrictions.
1
Limited in strenuous activity, but walking and able to do light work, such as housework or office work.
2
Walking and able to look after yourself, but unable to work; up and about more than half of waking hours.
3
Able to look after yourself only in part; in bed or a chair more than half of waking hours.
4
Unable to look after yourself at all; in bed or a chair all day.

Studies most often ask for 0–1 or 0–2. Your doctor gives the score; the WHO scale uses the same steps. The full scale also has 5, which records death.

05

Study design

Phase
Early Phase 1
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    BVN Block

    Patients will receive temporary basivertebral nerve block using lidocaine during the vertebral augmentation procedure for osteoporotic compression fracture.

    Procedure: Basivertebral nerve block · Drug: Lidocaine induced basivertebral nerve block

Interventions

  • ProcedureBasivertebral nerve block

    Temporary intraosseous basivertebral nerve block using lidocaine

    Also known as: BVN block during vertebral augmentation

  • DrugLidocaine induced basivertebral nerve block

    Intraosseous lidocaine basivertebral nerve block

    Also known as: Lidocaine BVN block

06

What researchers measure

Primary outcomes

  1. Pre-procedure Pain Score

    Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. VAS pain scores will be obtained upon preprocedural consultation.

    Time frame: At pre-procedure consultation.

  2. Immediate Post-procedure Pain Score

    Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. VAS pain scores will be obtained immediately post-procedure.

    Time frame: In the immediate post-procedure period in recover.

  3. One-week Post-procedure Pain Score

    Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. VAS pain scores will be obtained at one-week post-procedure follow-up in clinic.

    Time frame: At one-week post procedure follow-up.

  4. Immediate Post-procedure Satisfaction Score

    Patients will be asked to rate their satisfaction using a subjective Likert scale of 1 - 4, in the immediate post-procedure period during recovery. Satisfaction ratings were defined as follows: 1 = completely dissatisfied, 2 = dissatisfied, 3 = satisfied, 4 = very satisfied.

    Time frame: Assessed at one-week post procedure follow-up.

  5. One-week Post-procedure Satisfaction Score

    Patients will be asked to rate their satisfaction using a subjective Likert scale of 1 - 4, at one week clinical follow-up. Satisfaction ratings were defined as follows: 1 = completely dissatisfied, 2 = dissatisfied, 3 = satisfied, 4 = very satisfied.

    Time frame: At one-week post-procedure follow-up.

Secondary outcomes

  1. Heart rate disturbance

    \>20% change from baseline heart rate as measured in beats per minute (BPM)

    Time frame: Intraprocedural

  2. Blood pressure disturbance

    \>20% change from baseline systolic or diastolic blood pressure as measured in mm of Mercury (mmHg)

    Time frame: Intraprocedural

  3. Need for additional anesthesia or sedation

    Intraprocedural monitoring for patient pain in real time during the procedure. Need for additional pain or sedative medication such as Fentanyl or Versed, at the discretion of the interventional radiologist performing the procedure.

    Time frame: Intraprocedural

  4. Intraprocedural pain during balloon augmentation

    Special attention to patient pain will be assessed during intraprocedural balloon augmentation, as this is often the most painful part of the procedure. Subjective pain as measured using a standard Visual Analog Scale (VAS) of 0-10, where 0 represents no pain, and 10 indicates the worst pain of the patient's life. Additional routine monitoring of pain will take place during the procedure as carried out by the circulating nurse and by the interventional radiologist performing the procedure.

    Time frame: Intraprocedural

07

Study locations

1 site
  • Northwell Health Mather Hospital
    Port Jefferson, New York 11777, United States
08

References and documents

Individual participant data

Plan to share: No — Data will be made available upon request at the discretion of the primary investigator.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04774029
Lead sponsor
Northwell Health
Responsible party
Sponsor
First posted
Feb 26, 2021
Start date
Jan 10, 2020
Primary completion
Apr 1, 2020
Completion
May 1, 2020
Last update
Feb 26, 2021

Study contacts

Kenny Lien, MD
principal investigator · Northwell Health - Mather Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion